Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Horizon Therapeutics
(NQ:
HZNP
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Oct 5, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Horizon Therapeutics
< Previous
1
2
3
4
5
6
7
8
9
...
16
17
Next >
HORIZON THERAPEUTICS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Horizon Therapeutics Public Limited Company - HZNP
January 25, 2023
From
Kahn Swick & Foti, LLC
Via
Business Wire
Rule 17 (b) Announcement – Horizon Therapeutics plc
January 23, 2023
From
Horizon Therapeutics plc
Via
Business Wire
Rule 17 (a) Announcement – Horizon Therapeutics plc
January 23, 2023
From
Horizon Therapeutics plc
Via
Business Wire
Horizon Therapeutics Touts Positive Data From Mid-Stage Study For Immune System Disorder
January 18, 2023
Via
Benzinga
$1000 Invested In Horizon Therapeutics 5 Years Ago Would Be Worth This Much Today
January 10, 2023
Via
Benzinga
$100 Invested In Horizon Therapeutics 10 Years Ago Would Be Worth This Much Today
December 27, 2022
Via
Benzinga
A Bullish Sign Appears On Horizon Therapeutics's Chart
December 27, 2022
Via
Benzinga
Horizon Therapeutics plc Announces Phase 2 Trial Evaluating Dazodalibep for the Treatment of Sjögren’s Syndrome Meets Primary Endpoint in the Second Study Population; Only Phase 2 Trial to Meet Primary Endpoint in Both Patient Populations
January 18, 2023
From
Horizon Therapeutics plc
Via
Business Wire
Rule 2.12 Announcement – Horizon Therapeutics plc
January 12, 2023
From
Horizon Therapeutics plc
Via
Business Wire
3 Biotech Companies to Watch in 2023
January 06, 2023
These biotech companies to watch are remarkably strong businesses that offer healthy upside potential as we head into a new year.
Via
InvestorPlace
5 Top Pharma Stocks of 2022 to Buy for the Long Haul
January 06, 2023
The biggest drug company blockbusters bring in billions of dollars, which is one of the reasons to consider these top Pharma stocks.
Via
InvestorPlace
Rule 8.1 Dealing Disclosure (Horizon Therapeutics plc)
January 06, 2023
From
Horizon Therapeutics plc
Via
Business Wire
Rule 8.1 Dealing Disclosure (Horizon Therapeutics plc)
January 04, 2023
From
Horizon Therapeutics plc
Via
Business Wire
Horizon Therapeutics plc Announces First Patient Enrolled in Phase 2 Trial Evaluating Daxdilimab for the Treatment of Discoid Lupus Erythematosus
January 04, 2023
From
Horizon Therapeutics plc
Via
Business Wire
Rule 8.1 Dealing Disclosure (Horizon Therapeutics plc)
January 03, 2023
From
Horizon Therapeutics plc
Via
Business Wire
5 Most Expensive Health Care Stocks You Should Worry About
January 03, 2023
The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
December 29, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
2 Market-Beating Stocks to Buy in 2023 and Hold Forever
December 24, 2022
For these companies' shareholders, it may be tempting to take profits right now. But both stocks can keep growing for a while.
Via
The Motley Fool
How Did 2022’s Most Loved Stocks By Analysts Fare?
December 24, 2022
Looking at just stocks with coverage from at least eight analysts, the average Russell 1,000 stock had about 59% buy ratings at the start of 2022.
Via
Talk Markets
Universal Health Services, Madrigal Pharmaceuticals And These Overbought Majors In The Healthcare Sector
December 23, 2022
The most overbought stocks in the healthcare sector presents an opportunity to go short on these overvalued companies.
Via
Benzinga
Analyzing Horizon Therapeutics's Short Interest
December 22, 2022
Horizon Therapeutics's (NASDAQ:HZNP) short percent of float has fallen 7.07% since its last report. The company recently reported that it has 6.49 million shares sold short, which is 2.89% of all...
Via
Benzinga
2 No-Brainer Biotech Stocks to Buy Right Now
December 22, 2022
Vertex Therapeutics and Amgen have the building blocks for long-term success.
Via
The Motley Fool
Interest Rate Hikes Won't Stop These 2 Cash-Rich Growth Stocks
December 21, 2022
Even if interest rates go up, you likely won't need to worry about these stocks.
Via
The Motley Fool
UPLIZNA® (inebilizumab-cdon) Approved in Brazil for the Treatment of Neuromyelitis Optica Spectrum Disorder (NMOSD)
December 20, 2022
From
Horizon Therapeutics plc
Via
Business Wire
Market Rally Pressured On Fed Rate Outlook; Moderna, Boeing, Tesla In Focus: Weekly Review
December 16, 2022
Moderna spiked on a cancer vaccine while Tesla continued to dive.
Via
Investor's Business Daily
Pfizer, Novartis Are Among Overbought Healthcare Stocks: Are They Worth A Look?
December 14, 2022
The most overbought stocks in the healthcare sector presents an opportunity to go short on these overvalued companies. Here’s the latest list of major overbought players in this sector, with an RSI...
Via
Benzinga
HORIZON THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Horizon Therapeutics Public Limited Company - HZNP
December 13, 2022
From
Kahn Swick & Foti, LLC
Via
Business Wire
Form 8.1 Opening Position Disclosure (Horizon Therapeutics plc)
December 13, 2022
From
Horizon Therapeutics plc
Via
Business Wire
Cramers Says These 3 Big Deals Aided Monday's Market Rally: 'When Companies Start Buying Each Other At A Big Premium...'
December 13, 2022
Prominent market commentator Jim Cramer said three corporate deals announced on Monday aided the rally seen at the beginning of the week,
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 13, 2022
December 13, 2022
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
16
17
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.